VANCOMYCIN PHARMACOKINETICS IN PEDIATRIC PATIENTS WITH FEBRILE NEUTROPENIA (FN): EFFECT OF AUGMENTED RENAL CLEARANCE (ARC).

被引：0
|
作者：
Shimamoto, Y. [1 ]
Mizuno, T. [2 ,3 ]
Verstegen, R. [1 ]
Allen, U. [1 ]
Ito, S. [1 ,4 ]
机构：
[1] Hosp Sick Children, Toronto, ON, Canada
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[3] Univ Cincinnati Coll, Cincinnati, OH USA
[4] Univ Toronto, Toronto, ON, Canada
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2020年 / 107卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PIII-100
引用
下载
收藏
页码：S105 / S105
页数：1
相关论文
共 50 条
  • [41] PEGFILGRASTIM ADMINISTRATION TIMING AND ITS EFFECT ON FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS
    Mack, Joana
    Spray, Beverly
    Mack, Delanie
    Mason, Katherine
    Becton, David
    Bielamowicz, Kevin
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [42] Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence
    Karandikar, Manjiree, V
    Milliren, Carly E.
    Zaboulian, Robin
    Peiris, Poornima
    Sharma, Tanvi
    Place, Andrew E.
    Sandora, Thomas J.
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (04) : 428 - 436
  • [43] USE OF ARCTIC SCORE FOR VANCOMYCIN DOSING IN TRAUMA PATIENTS AT RISK FOR AUGMENTED RENAL CLEARANCE
    Molina, Kyle
    Hall, Scott
    Barletta, Jeffrey
    Mangram, Alicia
    Huang, Vanthida
    CRITICAL CARE MEDICINE, 2019, 47
  • [44] Population Pharmacokinetic Modeling and Dose Optimization of Vancomycin in Chinese Patients with Augmented Renal Clearance
    Zhao, Sixuan
    He, Na
    Zhang, Yahui
    Wang, Chuhui
    Zhai, Suodi
    Zhang, Chao
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [45] Scoping review of augmented renal clearance in critically ill pediatric patients
    Rhoney, Denise H.
    Metzger, Samuel A.
    Neslon, Nicholas R.
    PHARMACOTHERAPY, 2021, 41 (10): : 851 - 863
  • [46] Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance
    Nicolau, David P.
    De Waele, Jan
    Kuti, Joseph L.
    Caro, Luzelena
    Larson, Kajal B.
    Yu, Brian
    Gadzicki, Elaine
    Zeng, Zhen
    Rhee, Elizabeth G.
    Rizk, Matthew L.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 57 (04)
  • [47] Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearance
    Fratoni, Andrew J.
    Mah, John W.
    Nicolau, David P.
    Kuti, Joseph L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (11) : 2992 - 2999
  • [48] PHARMACOKINETICS OF VANCOMYCIN IN PEDIATRIC-PATIENTS
    SCHAAD, UB
    MCCRACKEN, GH
    NELSON, JD
    PEDIATRIC RESEARCH, 1979, 13 (04) : 373 - 373
  • [49] The impact of a multimodal approach to vancomycin discontinuation in hematopoietic stem cell transplant recipients (HSCT) with febrile neutropenia (FN)
    Perreault, Sarah
    McManus, Dayna
    Bar, Noffar
    Foss, Francine
    Gowda, Lohith
    Isufi, Iris
    Seropian, Stuart
    Malinis, Maricar
    Topal, Jeffrey E.
    TRANSPLANT INFECTIOUS DISEASE, 2019, 21 (02)
  • [50] Time-to-Antibiotics (TTA) and outcomes in cancer patients with febrile neutropenia (FN)
    Perron, T.
    Ahmed, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S316 - S316
12345